MedTrace Logo

HPV Vaccine Reminders - SEARCH II Study

NCT06161831 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 396

Last updated 2025-09-08

No results posted yet for this study

Summary

This RCT will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic in Kampala. The investigators will assess the impact of vaccine text message and automated phone reminders on human papillomavirus (HPV) vaccination initiation and completion.

Conditions

  • Human Papillomavirus Vaccination

Interventions

BEHAVIORAL

Text Message/automated phone reminder

Receipt of text message or automated phone reminders notifying when the next HPV vaccine dose is due (either first or second)

Sponsors & Collaborators

  • Makerere University

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • Melissa S Stockwell, MD MPH · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
14 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-22
Primary Completion
2026-05-31
Completion
2026-07-31

Countries

  • United States
  • Uganda

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06161831 on ClinicalTrials.gov